Well Lead Medical Co

Well Lead Medical Co FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Well Lead Medical Co (603309.SS) as of Oct 23, 2026 is 162.60 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was -4.32 % — a change of -3,866.99% (higher).

FCF Conversion

162.60 %

YoY

-3,866.99%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Well Lead Medical Co is 2025 162.60 % . FCF Conversion Rate (FCF/EBITDA) of Well Lead Medical Co was 2024 -4.32 % . It decreases by -3,866.99% higher compared to the previous year.

The Well Lead Medical Co FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
17.16 CNY
Jan 1, 2019
54.69 CNY
Jan 1, 2020
88.80 CNY
Jan 1, 2021
73.52 CNY
Jan 1, 2022
125.92 CNY
Jan 1, 2023
-64.61 CNY
Jan 1, 2024
-4.32 CNY
Jan 1, 2025
162.60 CNY
The Well Lead Medical Co FCF Conversion history
YEARFCF ConversionYoY
162.60 %-3,866.99%
-4.32 %-93.32%
-64.61 %-151.31%
125.92 %+71.27%
73.52 %-17.20%
88.80 %+62.36%
54.69 %+218.64%
17.16 %+243.58%
5.00 %-75.88%
20.71 %-57.48%
48.71 %-40.86%
82.36 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Well Lead Medical Co Stock analysis

What does Well Lead Medical Co do? Well Lead Medical Co., Ltd. generates revenue through the research, development, production, and sales of medical equipment for anesthesia, urology, nursing, respiratory, and hemodialysis applications. The company's major products include endotracheal intubations, urethral catheters, laryngeal masks, and hemodialysis catheters, which are used in clinical settings such as hospitals, surgeries, treatments, first aid, and nursing. Domestic and overseas markets are the primary channels for distributing these products, serving healthcare facilities that require specialized medical equipment for surgical procedures, emergency care, and patient treatment. The firm targets hospitals, surgical centers, and healthcare providers as key customers, leveraging its product range to address needs in anesthesia, urology, respiratory care, and hemodialysis. By focusing on clinical applications in surgery, treatment, emergency care, and nursing, Well Lead Medical ensures its equipment meets the demands of medical professionals across various hospital departments. The company's domestic and international distribution network supports its presence in both local and global healthcare markets. Well Lead Medical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Well Lead Medical Co stock

FCF Conversion Rate (FCF/EBITDA) of Well Lead Medical Co is 162.60 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Well Lead Medical Co changed from -4.32 % to 162.60 %, representing a -3,866.99% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Well Lead Medical Co since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Well Lead Medical Co with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Well Lead Medical Co

All Key Metrics — Well Lead Medical Co